KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Other Non-Current Liabilities (2016 - 2025)

Pfizer (PFE) has disclosed Other Non-Current Liabilities for 17 consecutive years, with $3.6 billion as the latest value for Q4 2025.

  • Quarterly Other Non-Current Liabilities fell 41.25% to $3.6 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.6 billion through Dec 2025, down 41.25% year-over-year, with the annual reading at $3.6 billion for FY2025, 41.25% down from the prior year.
  • Other Non-Current Liabilities for Q4 2025 was $3.6 billion at Pfizer, up from $3.4 billion in the prior quarter.
  • The five-year high for Other Non-Current Liabilities was $16.5 billion in Q4 2023, with the low at $3.3 billion in Q2 2025.
  • Average Other Non-Current Liabilities over 5 years is $9.1 billion, with a median of $9.5 billion recorded in 2021.
  • The sharpest move saw Other Non-Current Liabilities skyrocketed 99.89% in 2024, then crashed 79.42% in 2025.
  • Over 5 years, Other Non-Current Liabilities stood at $9.7 billion in 2021, then increased by 0.71% to $9.8 billion in 2022, then surged by 68.56% to $16.5 billion in 2023, then crashed by 63.04% to $6.1 billion in 2024, then crashed by 41.25% to $3.6 billion in 2025.
  • According to Business Quant data, Other Non-Current Liabilities over the past three periods came in at $3.6 billion, $3.4 billion, and $3.3 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.